RichardDalePressMDPhD

PubMed

• Overcoming clinical BCR-ABL1 compound mutant resistance with combined ponatinib and asciminib therapy.
  Christopher A Eide, Diana Brewer, Tao Xie, Anna Reister Schultz, Samantha L Savage
  Cancer Cell. 2024-09-09
• Clonally related benign cephalic histiocytosis, histiocytic sarcoma, and T-cell acute lymphoblastic leukemia: Expanding the spectrum of histiocytic transdifferentiation.
  J Connor Thellman, Milie M Fang, Tanaya Neff, George Thomas, Candace Frerich
  Pediatric Blood & Cancer. 2024-09-01
• 9 citations
  The genomic basis of childhood T-lineage acute lymphoblastic leukaemia.
  Petri Pölönen, Danika Di Giacomo, Anna Eames Seffernick, Abdelrahman Elsayed, Shunsuke Kimura
  Nature. 2024-08-01

Journal Articles

• Discriminating a Common Somatic ASXL1 Mutation (c.1934dup; p.G646Wfs*12) from Artifact in Myeloid Malignancies Using NGS  
  Jonathan W Heusel, Richard D Press, Matthew J Walter, Eric J Duncavage, Nature
• CRISPR-Cas9–Mediated Saturated Mutagenesis Screen Predicts Clinical Drug Resistance with Improved Accuracy  
  Richard D Press, Brian J Druker, Michael R Green, Proceedings of the National Academy of Sciences

Abstracts/Posters

• Framework to Identify and Prioritize Candidate Inherited Myeloid Malignancy Germline Variants Leveraging the BEAT AML Cohort
  Richard D. Press, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Clinical Utility of a Multi-Gene Next-Generation Sequencing Myeloid Panel in an Academic Hematology Practice
  Richard D. Press, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• A Novel Germline Variant in CSF3R Reduces N-glycosylation and Exerts Potent Oncogenic Effects in Leukemia
  Richard Press, MD, Clinical Cancer Research, Orlando, FL, 12/8/2019